EuBiologics Co., Ltd. (206650.KQ) KOE
9,900.00
+80(+0.81%)
Currency In KRW
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 416.59B |
| Enterprise Value | 396.92B |
| P/E Ratio | 12.43 |
| PEG Ratio | -0.51 |
| Price/Sales Ratio | 2.89 |
| Price/Book Ratio | 2.02 |
| Enterprise/Revenue | 2.72 |
| Enterprise/EBITDA | 5.99 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | 0.23 |
| Operating Margin | 0.37 |
Management Effectiveness
| Return On Assets | 0.12 |
| Return On Equity | 0.17 |
Income Statement
| Revenue | 149.2B |
| Revenue/Share | 3,414.16 |
| Gross Profit | 85.35B |
| EBITDA | 70.66B |
| Net Income | 41.26B |
| Diluted EPS | 1,124.73 |
Balance Sheet
| Total Cash | 78.1B |
| Total Cash/Share | 2,127.49 |
| Total Debt | 0 |
| Total Debt/Equity | 0 |
| Current Ratio | 3.99 |
| Book Value Per Share | 4,895.9 |
Price History
| 52-Week Change | -22.6 |
| 52-Week High | 17,700 |
| 52-Week Low | 9,600 |
| Moving Average 50 Days | 12,603 |
| Moving Average 200 Days | 12,875.35 |
Statistics
| Average Volume | 310,115 |
| Shares Outstanding | 36.62M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 517:500 |
| Last Split Date | November 12, 2020 |
